tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VRTX Stock Latest News

Insiders Snap Up These 2 Stocks on the Dip — Here’s Why They Draw Plaudits from Goldman Sachs
Market NewsInsiders Snap Up These 2 Stocks on the Dip — Here’s Why They Draw Plaudits from Goldman Sachs
2d ago
FOUR
VRTX
ON Semiconductor, Block, Digital Turbine, RingCentral, Vertex: Trending by Analysts
PremiumWeekend Updates
ON Semiconductor, Block, Digital Turbine, RingCentral, Vertex: Trending by Analysts
7d ago
ON
RNG
Vertex Pharmaceuticals downgraded to Neutral from Buy at DA Davidson
PremiumThe Fly
Vertex Pharmaceuticals downgraded to Neutral from Buy at DA Davidson
9d ago
VRTX
Vertex Pharmaceuticals: Hold Rating Amid Mixed Q2 Results and Pain Management Setbacks
PremiumRatings
Vertex Pharmaceuticals: Hold Rating Amid Mixed Q2 Results and Pain Management Setbacks
10d ago
VRTX
Vertex Pharmaceuticals: Strong Commercial Performance and Promising Future Prospects Support Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Strong Commercial Performance and Promising Future Prospects Support Buy Rating
10d ago
VRTX
Vertex Pharmaceuticals: Hold Rating Amid Growth Concerns and Market Challenges
PremiumRatingsVertex Pharmaceuticals: Hold Rating Amid Growth Concerns and Market Challenges
10d ago
VRTX
Vertex Pharmaceuticals: Buy Rating Upgraded to Overweight Amid Promising Pipeline and Strong Financial Position
Premium
Ratings
Vertex Pharmaceuticals: Buy Rating Upgraded to Overweight Amid Promising Pipeline and Strong Financial Position
10d ago
VRTX
Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
Premium
The Fly
Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
10d ago
U
GO
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
10d ago
IT
ALC
Vertex Pharmaceuticals price target lowered to $411 from $424 at Canaccord
PremiumThe Fly
Vertex Pharmaceuticals price target lowered to $411 from $424 at Canaccord
10d ago
VRTX
Vertex Pharmaceuticals upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Vertex Pharmaceuticals upgraded to Overweight from Equal Weight at Wells Fargo
10d ago
VRTX
Vertex Pharmaceuticals: Strong Growth and Strategic Advances
PremiumCompany Announcements
Vertex Pharmaceuticals: Strong Growth and Strategic Advances
11d ago
VRTX
Video: Palantir, Axon lead early movers after earnings
PremiumThe FlyVideo: Palantir, Axon lead early movers after earnings
11d ago
IT
TDG
video: Why These Stocks Are Moving Today
Premium
The Fly
video: Why These Stocks Are Moving Today
11d ago
IT
TDG
Vertex Pharmaceuticals price target lowered to $490 from $520 at Truist
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $490 from $520 at Truist
11d ago
VRTX
Vertex Pharmaceuticals price target lowered to $455 from $494 at Stifel
PremiumThe Fly
Vertex Pharmaceuticals price target lowered to $455 from $494 at Stifel
11d ago
VRTX
Vertex Pharmaceuticals price target lowered to $553 from $582 at UBS
PremiumThe Fly
Vertex Pharmaceuticals price target lowered to $553 from $582 at UBS
11d ago
VRTX
Vertex Pharmaceuticals price target lowered to $530 from $557 at BMO Capital
PremiumThe Fly
Vertex Pharmaceuticals price target lowered to $530 from $557 at BMO Capital
11d ago
VRTX
Vertex price target lowered to $478 from $550 at H.C. Wainwright
PremiumThe Fly
Vertex price target lowered to $478 from $550 at H.C. Wainwright
11d ago
VRTX
Vertex Pharmaceuticals price target lowered to $439 from $460 at Morgan Stanley
PremiumThe FlyVertex Pharmaceuticals price target lowered to $439 from $460 at Morgan Stanley
11d ago
VRTX
Vertex Pharmaceuticals: Strong Financials Overshadowed by Challenges in Pain Program Leading to Hold Rating
Premium
Ratings
Vertex Pharmaceuticals: Strong Financials Overshadowed by Challenges in Pain Program Leading to Hold Rating
11d ago
VRTX
Vertex Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Vertex Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
11d ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >